Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Becton Dickinson
(NY:
BDX
)
229.06
+1.56 (+0.69%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Becton Dickinson
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
March 28, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
March 27, 2025
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
March 24, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Price Over Earnings Overview: Becton Dickinson
January 17, 2025
Via
Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
January 17, 2025
Via
Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
December 13, 2024
Via
Benzinga
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
March 21, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Stay informed with the top movers within the S&P500 index on Tuesday.
March 18, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
March 18, 2025
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via
Chartmill
How Do Investors Really Feel About Becton Dickinson?
March 17, 2025
Via
Benzinga
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
March 10, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
10 KISS Stocks For Reliable Retirement Income
March 06, 2025
Retirement investing should be kept simple in order to minimize mistakes. At its core, retirement investing is all about creating passive income.
Via
Talk Markets
Topics
Retirement
Stocks / Equities
Exposures
Pension
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
March 05, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
3 Reasons to Sell BDX and 1 Stock to Buy Instead
February 28, 2025
Over the past six months, BD’s shares (currently trading at $224.85) have posted a disappointing 5.9% loss, well below the S&P 500’s 5.1% gain. This might have investors contemplating their next move.
Via
StockStory
Topics
Stocks
Exposures
US Equities
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 26, 2025
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for.
Via
StockStory
3 Dividend Stocks Trading At A Discount
February 21, 2025
These 3 dividend stocks have increased their dividends for over 50 years and are trading at a discounted valuation.
Via
Talk Markets
Topics
Stocks / Equities
10 Overlooked Dividend Powerhouses Trading At A Discount
February 19, 2025
Via
Talk Markets
Topics
Stocks / Equities
Healthcare And Biotech Playbook As Disruption Gathers Force
February 10, 2025
The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
February 06, 2025
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.
Via
Benzinga
BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect
February 05, 2025
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for.
Via
StockStory
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
February 03, 2025
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to...
Via
Benzinga
Biotech And Healthcare Stocks Poised For Gains Ahead
January 27, 2025
The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
January 23, 2025
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments.
Via
Benzinga
Topics
Artificial Intelligence
Government
Stocks
Exposures
Artificial Intelligence
Political
US Equities
5 Stocks to Sell Before Trump's Mexico Tariffs
January 07, 2025
Stocks to sell ahead of tariffs on Mexico: General Motors and Whirlpool have significant exposure to Mexican production facilities.
Via
Benzinga
Topics
Government
World Trade
Exposures
Political
Tariff
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
January 06, 2025
The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
10 Buy And Hold Forever Dividend Stocks
December 25, 2024
The following 10 stocks represent Dividend Kings that can continue to raise their dividends for decades to come.
Via
Talk Markets
Topics
Stocks / Equities
Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation
December 21, 2024
Becton, Dickinson and Co. pays a $175 million civil penalty and Express fails to disclose its former CEO's full compensation.
Via
Benzinga
13 Healthcare Sector Stocks With Healthy Valuation
December 05, 2024
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Exposures
US Equities
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
November 26, 2024
Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring plans with cost-saving measures.
Via
Benzinga
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
November 15, 2024
Altria Group is "undervalued," Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.